Secular trends, treatments, and outcomes of middle eastern arab and south asian patients hospitalized with atrial fibrillation: Insights from a 20-year registry in Qatar (1991-2010)

Angiology

Volumn 64, Issue 7, 2013, Pages 498-504

  Salam, Amar M ^a   Albinali, Hajar A ^a   Al Mulla, Abdul Wahid ^a   Singh, Rajvir ^a   Suwaidi, Jassim Al ^a  

^a HAMAD MEDICAL CORPORATION   (Qatar)

Author keywords

Arabs; Asian; atrial fibrillation; ethnicity; prevalence; trends

Indexed keywords

ACUTE CORONARY SYNDROME; ADULT; ARAB; ARTICLE; ASIAN; CEREBROVASCULAR ACCIDENT; CHRONIC KIDNEY FAILURE; CONGESTIVE HEART FAILURE; DIABETES MELLITUS; DYSLIPIDEMIA; ETHNICITY; HEART ATRIUM FIBRILLATION; HOSPITALIZATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MORTALITY; PROSPECTIVE STUDY; QATAR; REGISTER; SOUTH ASIA; TREATMENT OUTCOME; VALVULAR HEART DISEASE;

ARABS; ASIAN; ATRIAL FIBRILLATION; ETHNICITY; PREVALENCE; TRENDS;

ADULT; AGED; ARABS; ASIAN CONTINENTAL ANCESTRY GROUP; ATRIAL FIBRILLATION; FEMALE; HOSPITAL MORTALITY; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDIES; QATAR; REGISTRIES; SURVIVAL RATE;

EID: 84883355586     PISSN: 00033197     EISSN: 19401574     Source Type: Journal    
DOI: 10.1177/0003319712460332     Document Type: Article

References (35)

1. Roger VL, Go AS, Lloyd-Jones DM, et al. American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics - 2012 update: a report from the American Heart Association. Circulation. 2012 ; 125 (1). e2 - e220
2. Piccini JP, Hammill BG, Sinner MF, et al. Incidence and prevalence of atrial fibrillation and associated mortality among Medicare beneficiaries, 1993-2007. Circ Cardiovasc Qual Outcomes. 2012 ; 5 (1). 85-93
3. Miyasaka Y, Barnes ME, Gersh BJ, et al. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation. 2006 ; 114 (2). 119-125
4. Reiffel JA. Atrial fibrillation: what have recent trials taught us regarding pharmacologic management of rate and rhythm control?. Pacing Clin Electrophysiol. 2011 ; 34 (2). 247-259
5. Kurian AK, Cardarelli KM. Racial and ethnic differences in cardiovascular disease risk factors: a systematic review. Ethn Dis. 2007 ; 17 (1). 143-152
6. Soliman EZ, Alonso A, Goff DC. Atrial fibrillation and ethnicity: the known, the unknown and the paradox. Future Cardiol. 2009 ; 5 (6). 547-556
7. El-Menyar AA, Albinali HA, Bener A, Mohammed I, Al Suwaidi J. Prevalence and impact of diabetes mellitus in patients with acute myocardial infarction: a 10-year experience. Angiology. 2009 ; 60 (6). 683-688
8. Al Suwaidi J, Al-Qahtani A, Asaad N, Al-Mulla AW, Singh R, Albinali HA. Comparison of women versus men hospitalized with heart failure (from a 20-year registry in a middle-eastern country 1991-2010). Am J Cardiol. 2012 ; 109 (3). 395-400
9. Hadi HA, Al Suwaidi J, Bener A, Khinji A, Al Binali HA. Thrombolytic therapy use for acute myocardial infarction and outcome in Qatar. Int J Cardiol. 2005 ; 102 (2). 249-254
10. Al Suwaidi J, Asaad N, Al-Qahtani A, Al-Mulla AW, Singh R, Albinali HA. Prevalence and outcome of Middle-Eastern Arab and South Asian patients hospitalized with heart failure: insight from a 20-year registry in a Middle-Eastern country. Acute Card Care. 2012 ; 14 (2). 81-89
11. Ramaraj R, Chellappa P. Cardiovascular risk in South Asians. Postgrad Med J. 2008 ; 84 (996). 518-523
12. Mangalmurti SS, Paley A, Gany F, Fisher EA, Hochman JS. South Asians and risk of cardiovascular disease: current insights and trends. Ethn Dis. 2010 ; 20 (4). 474-478
13. Ajjan R, Carter AM, Somani R, Kain K, Grant PJ. Ethnic differences in cardiovascular risk factors in healthy Caucasian and South Asian individuals with the metabolic syndrome. J Thromb Haemost. 2007 ; 5 (4). 754-760
14. Borzecki AM, Bridgers DK, Liebschutz JM, Kader B, Kazis LE, Berlowitz DR. Racial differences in the prevalence of atrial fibrillation among males. J Natl Med Assoc. 2008 ; 100 (2). 237-245
15. Ruo B, Capra AM, Jensvold NG, Go AS. Racial variation in the prevalence of atrial fibrillation among patients with heart failure: the Epidemiology, Practice, Outcomes, and Costs of Heart Failure (EPOCH) study. J Am Coll Cardiol. 2004 ; 43 (3). 429-435
16. Small KM, Wagoner LE, Levin AM, Kardia SL, Liggett SB. Synergistic polymorphisms of beta1- and alpha2C-adrenergic receptors and the risk of congestive heart failure. N Engl J Med. 2002 ; 347 (15). 1135-1134
17. Manolio TA, Gottdiener JS, Tsang TS, Gardin JM. Left atrial dimensions determined by M-mode echocardiography in black and white older (> or =65 years) adults (The Cardiovascular Health Study). Am J Cardiol. 2002 ; 90 (9). 983-987
18. Wang TJ, Larson MG, Levy D, et al. Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med. 2004 ; 350 (7). 655-663
19. Rossi A, Enriquez-Sarano M, Burnett JC, Lerman A, Abel MD, Seward JB. Natriuretic peptide levels in atrial fibrillation: a prospective hormonal and Doppler-echocardiographic study. J Am Coll Cardiol. 2000 ; 35 (5). 1256-1262
20. Ellinor PT, MacRae CA. Ion channel mutations in AF: signal or noise?. Heart Rhythm. 2008 ; 5 (3). 436-437
21. Lip GY. Stroke in atrial fibrillation: epidemiology and thromboprophylaxis. J Thromb Haemost. 2011 ; 9 (suppl 1). 344-351
22. Stafford RS, Singer DE. National patterns of warfarin use in atrial fibrillation. Arch Intern Med. 1996 ; 156 (22). 2537-2541
23. Waldo AL, Becker RC, Tapson VF, Colgan KJ. Hospitalized patients with atrial fibrillation and a high risk of stroke are not being provided with adequate anticoagulation. J Am Coll Cardiol. 2005 ; 46 (9). 1729-1736
24. Majeed A, Moser K, Carroll K.. Trends in the prevalence and management of atrial fibrillation in general practice in England and Wales, 1994-1998: analysis of data from the general practice research database. Heart. 2001 ; 86 (3). 284-288
25. Sudlow M, Thomson R, Thwaites B, Rodgers H, Kenny RA. Prevalence of atrial fibrillation and eligibility for anticoagulants in the community. Lancet. 1998 ; 352 (9135). 1167-1171
26. Kalra L, Yu G, Perez I, Lakhani A, Donaldson N. Prospective cohort study to determine if trial efficacy of anticoagulation for stroke prevention in atrial fibrillation translates into clinical effectiveness. BMJ. 2000 ; 320 (7244). 1236-1239
27. Go AS, Hylek EM, Borowsky LH, Phillips KA, Selby JV, Singer DE. Warfarin use among ambulatory patients with nonvalvular atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study. Ann Intern Med. 1999 ; 131 (12). 927-934
28. Pisters R, Lane DA, Nieuwlaat R, de Vos CB, Crijns HJ, Lip GY. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest. 2010 ; 138 (5). 1093-1100
29. Wheeldon NM, Tayler DI, Anagnostou E, Cook D, Wales C, Oakley GD. Screening for atrial fibrillation in primary care. Heart. 1998 ; 79 (1). 50-55
30. Miyasaka Y, Barnes ME, Bailey KR, et al. Mortality trends in patients diagnosed with first atrial fibrillation: a 21-year community-based study. J Am Coll Cardiol. 2007 ; 49 (9). 986-992
31. Taggar JS, Marín F, Lip GY. Mortality in patients with atrial fibrillation: improving or not?. Europace. 2008 ; 10 (4). 389-390
32. Pedersen OD, Abildstrøm SZ, Ottesen MM, et al. Increased risk of sudden and non-sudden cardiovascular death in patients with atrial fibrillation/flutter following acute myocardial infarction. Eur Heart J. 2006 ; 27 (3). 290-295
33. Rivero-Ayerza M, Scholte Op Reimer W, Lenzen M, et al. New-onset atrial fibrillation is an independent predictor of in-hospital mortality in hospitalized heart failure patients: results of the EuroHeart Failure Survey. Eur Heart J. 2008 ; 29 (13). 1618-1624
34. Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA. 2001 ; 285 (22). 2864-2870
35. Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest. 2010 ; 137 (2). 263-272